This index provides a structured navigation layer for the `gaps` section of NeuroWiki. Knowledge gaps are organized by disease area and research topic.
_Total: 55 pages_
Alzheimer's Disease
flowchart TD
gaps["Knowledge Gaps"]
style gaps fill:#4fc3f7,stroke:#333,color:#000
gaps_0["Alzheimers Disease"]
gaps -->|"includes"| gaps_0
style gaps_0 fill:#81c784,stroke:#333,color:#000
gaps_1["Parkinsons Disease"]
gaps -->|"includes"| gaps_1
style gaps_1 fill:#ef5350,stroke:#333,color:#000
gaps_2["Atypical Parkinsonisms"]
gaps -->|"includes"| gaps_2
style gaps_2 fill:#ffd54f,stroke:#333,color:#000
gaps_3["Tauopathies"]
gaps -->|"includes"| gaps_3
style gaps_3 fill:#ce93d8,stroke:#333,color:#000
gaps_4["ALS and Motor Neuron Disease"]
gaps -->|"includes"| gaps_4
style gaps_4 fill:#4fc3f7,stroke:#333,color:#000
gaps_5["Frontotemporal Dementia"]
gaps -->|"includes"| gaps_5
style gaps_5 fill:#81c784,stroke:#333,color:#000
... This index provides a structured navigation layer for the `gaps` section of NeuroWiki. Knowledge gaps are organized by disease area and research topic.
_Total: 55 pages_
Alzheimer's Disease
Mermaid diagram (expand to render)
[Alzheimer's Disease Knowledge Gaps](/gaps/alzheimers-disease)
[AD Knowledge Gaps Ranked: Prioritized Research Questions](/gaps/ad-knowledge-gaps-ranked)
[AD Cognitive Resilience: Why Some Amyloid-Positive Never Get Dementia](/gaps/ad-cognitive-resilience)
[Amyloid Removal Efficacy Knowledge Gap](/gaps/amyloid-removal-efficacy)
[Cerebral Amyloid Angiopathy in Alzheimer's Disease Knowledge Gaps](/gaps/cerebral-amyloid-angiopathy-ad)
[4R Tauopathy Biomarker Development](/gaps/4r-tauopathy-biomarkers)
[Tau Causality vs. Bystander in Alzheimer's Disease](/gaps/tau-causality-bystander-alzheimers)
[Optimal Therapeutic Intervention Timing in Alzheimer's Disease](/gaps/optimal-therapeutic-intervention-timing-alzheimers)
[Blood-Based Biomarkers for Early Neurodegeneration Detection](/gaps/blood-based-biomarkers-early-detection)
[Microbiome-Gut-Brain Axis in Alzheimer's Disease: Knowledge Gap](/gaps/microbiome-gut-brain-axis-ad)
Parkinson's Disease
[Parkinson's Disease Knowledge Gaps](/gaps/parkinsons)
[PD Knowledge Gaps Analysis](/gaps/pd-knowledge-gaps)
[Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's Disease](/gaps/alpha-synuclein-prion-spreading-parkinsons)
[LRRK2 Inhibition Disease Modification in Parkinson's Disease](/gaps/lrrk2-inhibition-disease-modification-pd)
[GLP-1 Receptor Agonist Responder Biology in Parkinson's Disease](/gaps/glp-1-responder-biology-parkinsons)
[Prodromal Prevention Trial Design in Parkinson's Disease](/gaps/prodromal-prevention-trial-design-parkinsons)
Atypical Parkinsonisms
[Progressive Supranuclear Palsy Knowledge Gaps](/gaps/progressive-supranuclear-palsy)
[Dementia with Lewy Bodies Knowledge Gaps](/gaps/dementia-lewy-bodies)
Tauopathies
[Tauopathy Knowledge Gaps](/gaps/tauopathies)
[Cell-Type-Specific Vulnerability in Tauopathies](/gaps/cell-type-specific-tauopathy-vulnerability)
[MAPT Mutation Penetrance and Phenotypic Modifiers in Tauopathies](/gaps/mapt-mutation-penetrance-phenotypic-modifiers)
ALS and Motor Neuron Disease
[ALS Knowledge Gaps](/gaps/als)
[ALS Motor Neuron Vulnerability](/gaps/als-motor-neuron-vulnerability)
[ALS Progression Rate Heterogeneity](/gaps/als-progression-rate-heterogeneity)
[ALS Regional Onset and Spread Patterns](/gaps/als-regional-onset-spread)
[ALS Trial Failures Knowledge Gap](/gaps/als-trial-failures)
[ALS Immune Signature Stratification for Clinical Trials](/gaps/als-immune-signature-stratification)
[Systemic Metabolic Dysfunction in ALS Progression](/gaps/systemic-metabolic-dysfunction-als)
[C9orf72 ALS-FTD Phenotype Divergence](/gaps/c9orf72-als-ftd-phenotype-divergence)
Frontotemporal Dementia
[Frontotemporal Dementia Knowledge Gaps](/gaps/ftd)
[GRN Carrier Resilience in Frontotemporal Dementia](/gaps/grn-carrier-resilience-ftd)
[Microglia in Frontotemporal Dementia Progression](/gaps/microglia-ftd-progression)
[Progranulin Deficiency and TDP-43 Aggregation in Frontotemporal Dementia](/gaps/progranulin-tdp43-ftd)
[Tau vs TDP-43 Fate Switching in Frontotemporal Dementia](/gaps/tau-vs-tdp-43-fate-switching-ftd)
[TDP-43 PET Ligand Development for Frontotemporal Dementia](/gaps/tdp-43-pet-ligand-ftd)
Huntington's Disease
[Huntington's Disease Knowledge Gaps](/gaps/huntingtons)
Prion Diseases
[Prion Disease Knowledge Gaps](/gaps/prion-disease)
Cross-Disease and General Research
[Aging and Rejuvenation Knowledge Gaps](/gaps/aging)
[Cross-Disease Shared Mechanisms Knowledge Gaps](/gaps/shared-mechanisms)
[Selective Neuronal Vulnerability to Aging](/gaps/selective-neuronal-vulnerability-aging)
[Sleep and Circadian Dysfunction in Neurodegeneration: Knowledge Gaps](/gaps/sleep-circadian-neurodegeneration)
[Subtype-Specific Target Engagement Biomarkers](/gaps/subtype-specific-target-engagement-biomarkers)
[Therapy Sequencing for Disease-Modifying Combinations in Neurodegeneration](/gaps/therapy-sequencing-combination-neurodegeneration)
Research Strategy and Prioritization
[Research Gap Overview](/gaps/overview)
[Gap Analysis and Research Strategy](/gaps/gap-analysis)
[Gap Priorities](/gaps/priorities)
[Gaps Rankings](/gaps/rankings)
[Priority Research Areas for Neurodegenerative Diseases](/gaps/priority-research-areas)
[Research Priorities in Neurodegenerative Disease](/gaps/research-priorities)
[Diseases](/diseases) — Disease-specific gaps
[Mechanisms](/mechanisms) — Mechanism gaps
[Therapeutics](/therapeutics) — Therapeutic gaps
[Biomarkers](/biomarkers) — Biomarker gaps
[Diagnostics](/diagnostics) — Diagnostic gaps
[Hypotheses](/hypotheses) — Research hypotheses
[Clinical Trials](/clinical-trials) — Clinical trial gaps
See Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
[Dementia with Lewy Bodies](/diseases/dementia-lewy-bodies)
[ALS](/diseases/amyotrophic-lateral-sclerosis)
[Frontotemporal Dementia](/diseases/frontotemporal-dementia)
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
[Excitatory Neuron Vulnerability via SLC17A7 Downregulation](/hypothesis/h-seaad-7f15df4c) — <span style="color:#81c784;font-weight:600">0.63</span> · Target: SLC17A7
Show full description